The letter written by Heinze (1) has serious shortcomings. Heinze 
107:A132 (1999 (1) compared the mortality of a cohort of members of the Church of Jesus Christ of Latter-day Saints (also known as Mormons) who were exposed to relatively high levels of arsenic through drinking water to the mortality of the general population of Utah. The authors concluded that arsenic exposure may be associated with hypertensive heart disease, nephritis and nephroma, prostate cancer in men, and other heart disease in women. No excess risks were reported for cancers such as those of the skin and bladder, which have been associated with arsenic in other studies (4. We believe that the comparison group used in this study, and the weight given on external rather than internal comparisons, complicates the interpretation of the study results.
Mormons are a selected group that differs from other groups of the general population in many ways, including lifestyle factors such as smoking, which are strong determinants of health. Lewis et al. (1) acknowledged that the study group is known to have about one-half the mortality rates of the general population for diseases such as respiratory and bladder cancers. Given this strong selection bias, it would be unlikely to find any excess risks for these diseases unless this risk associated with arsenic was very high. Similarly, high standard mortality ratios (SMRs) are likely to be caused by other general lifestyle factors, rather than arsenic in drinking water.
When the external comparison group is very different from the index group and information on potential confounders is not available, the best solution is to perform internal comparisons. If conclusions had been based on internal comparisons, neither hypertensive heart disease (SMRs of 2.4, 1.9, and 2.3 for low, medium, and high exposure to arsenic, respectively), nephritis/nephroma (SMRs of 2.0, 2.1, and 0.9, respectively), nor all other heart diseases (SMRs of 2.3, 1.4, and 0.7, respectively) would probably have been associated with arsenic in this study. Among the four causes that Lewis et al. (1) reported to be associated with arsenic, an increasing risk with exposure was only seen for prostate cancer. The authors did mention that internal comparisons are planned. Although such comparisons may be limited by small numbers, any conclusions from this study should await the conduct of such analyses.
